Radiation Therapy and Androgen Deprivation in the Management of High Risk Prostate Cancer EDITORIAL COMMENT

被引：0
|
作者：
Heyns, C. F. [1 ,2 ]
机构：
[1] Univ Stellenbosch, Dept Urol, ZA-7505 Tygerberg, South Africa
[2] Tygerberg Hosp, Tygerberg, South Africa
来源：
INTERNATIONAL BRAZ J UROL | 2011年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：176 / 177
页数：2
相关论文
共 50 条
  • [41] Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer
    Chen, Yu-Wei
    Muralidhar, Vinayak
    Mahal, Brandon A.
    Nezolosky, Michelle D.
    Beard, Clair J.
    Choueiri, Toni K.
    Hoffman, Karen E.
    Martin, Neil E.
    Orio, Peter F.
    Sweeney, Christopher J.
    Feng, Felix Y.
    Quoc-Dien Trinh
    Nguyen, Paul L.
    BRACHYTHERAPY, 2016, 15 (06) : 695 - 700
  • [42] Re: Intermittent versus Continuous Androgen Deprivation in Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2013, 190 (06): : 2093 - 2094
  • [43] Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer EDITORIAL COMMENTS
    Flaig, Thomas W.
    JOURNAL OF UROLOGY, 2013, 189 (01): : S43 - S43
  • [44] Androgen deprivation therapy and depression in the prostate cancer patients: review of risk and pharmacological management
    Alwhaibi, Abdulrahman
    Alsanea, Sary
    Almadi, Bana
    Al-Sabhan, Jawza
    Alosaimi, Fahad D.
    AGING MALE, 2022, 25 (01): : 101 - 124
  • [45] Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy
    Sebastian, Nikhil
    Goyal, Subir
    Liu, Yuan
    Janopaul-Naylor, James R.
    Patel, Pretesh R.
    Dhere, Vishal R.
    Hanasoge, Sheela
    Shelton, Jay W.
    Godette, Karen D.
    Jani, Ashesh B.
    Hershatter, Bruce
    Fischer-Valuck, Benjamin
    Patel, Sagar A.
    JAMA NETWORK OPEN, 2023, 6 (08) : e2327637
  • [46] PROSTATE CANCER AND ANDROGEN DEPRIVATION THERAPY-IS IT THE RIGHT MANAGEMENT?
    Goonewardene, Sanchia
    Sharp, Debbie
    Persad, Raj
    JOURNAL OF UROLOGY, 2015, 193 (04): : E935 - E935
  • [47] Androgen deprivation therapy for prostate cancer and the risk of thyroid diseases
    Liu, Jui-Ming
    Chen, Yu-Tang
    Wu, Chun-Te
    Hsu, Wen-Lin
    Hsu, Ren-Jun
    PROSTATE, 2022, 82 (07): : 809 - 815
  • [48] Fracture risk in patients with prostate cancer on androgen deprivation therapy
    López, AM
    Pena, MA
    Hernández, R
    Val, F
    Martín, B
    Riancho, JA
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (06) : 707 - 711
  • [49] Fracture risk in men with prostate cancer on androgen deprivation therapy
    Krupski, TL
    Smith, MR
    Lee, WC
    Pashos, CL
    Brandman, J
    Wang, Q
    Botteman, MF
    Litwin, MS
    JOURNAL OF UROLOGY, 2004, 171 (04): : 116 - 116
  • [50] Androgen-deprivation therapy in the management of neuroendocrine prostate cancer
    Martinez-Cornelio, Andres
    Gonzalez-Perez, Juventino
    de Jesus Tabares-Garcia, Felipe
    Ramos-Salgado, Francisco
    Alvarado-Cabrero, Isabel
    Hernandez-Toriz, Narciso
    CIRUGIA Y CIRUJANOS, 2009, 77 (04): : 273 - 278
12345